GlassScriptPhysician profile
Elizabeth A Bucher
NPI 1427458637
$3,628.97
in general payments reported to CMS, 2019-2025
29 companies · $1,395 in 2025
The $1,395 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $249 · 2022: $135 · 2023: $951 · 2024: $898 · 2025: $1,395.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,185 · Education: $35.06 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,185.34 |
| Education | $35.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $24.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $656.88 | 2023-2025 | Gemtesa |
| Teleflex LLC | $468.80 | 2023-2025 | Urolift, Barrigel |
| Convatec INC. | $407.20 | 2021-2025 | |
| Antares Pharma, INC. | $368.35 | 2021-2025 | Xyosted |
| Tolmar, INC. | $196.92 | 2023-2025 | Jatenzo, Eligard |
| Astellas Pharma US INC | $193.85 | 2021-2024 | Myrbetriq, Veozah |
| C. R. Bard, INC. & Subsidiaries | $182.67 | 2023 | Bard Urinary Drainage Bag |
| Bluewind Medical | $160.68 | 2025 | Revi |
| Ferring Pharmaceuticals INC. | $121.59 | 2024-2025 | Adstiladrin |
| 180 Medical, INC. | $110.10 | 2021-2024 | Gentlecath Glide, Gentlecath |
| Boston Scientific Corporation | $92.56 | 2025 | Axonics |
| Axonics, INC. | $85.48 | 2024 | Axonics |
| Abbvie INC. | $70.16 | 2021-2022 | |
| Endo Pharmaceuticals INC. | $66.31 | 2021-2023 | Xiaflex |
| Becton, Dickinson and Company | $65.55 | 2024-2025 | Magic3 Go Intermittent Urinary Catheter |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $58.69 | 2024-2025 | |
| Photocure INC | $47.50 | 2023-2025 | Cysview |
| Janssen Biotech, INC. | $41.62 | 2025 | Erleada |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Endo USA, INC. | $25.99 | 2025 | Xiaflex |
| Progenics Pharmaceuticals, INC. | $24.80 | 2023 | Pylarify |
| Dentsply Ih Ab | $23.92 | 2024 | Lofric |
| Halozyme INC | $21.93 | 2023 | |
| Tempus Ai, INC | $20.27 | 2025 | Xt Cdx |
| Abc Home Medical Supply, INC. | $20.26 | 2025 | |
| Coloplast Corp | $18.58 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.15 | 2022 | |
| Koelis INC. | $13.23 | 2023 | |
| Rochester Medical Corporation | $12.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Bucher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.